Ulcer healing in diabetic rats treated with aspirin, nitric oxide (NO)-derivative of aspirin and COX-2 inhibitor

被引：0
|
作者：
Brzozowski, T
Konturek, PC
Sliwowski, Z
Pawlik, M
Stachura, J
Konturek, SJ
Jaworek, J
Pawlik, WW
Hahn, EG
机构：
来源：
GASTROENTEROLOGY | 2003年 / 124卷 / 04期
关键词：
D O I：
10.1016/S0016-5085(03)80850-8
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：A171 / A171
页数：1
相关论文
共 50 条
  • [21] Aspirin, selective COX-2 inhibitors and gastrotolerance - Foreword
    Fiorucci, S
    Morelli, A
    Porro, GB
    DIGESTIVE AND LIVER DISEASE, 2001, 33 : S1 - S1
  • [22] The importance of COX-2 inhibition for aspirin induced asthma
    Bennett, A
    THORAX, 2000, 55 : S54 - S56
  • [23] Ulcer healing in rats treated wit aspirin (ASA) compared to a complex of ASA and phosphatidylcholine (PC).
    Kurinets, A
    Lichtenberger, LM
    GASTROENTEROLOGY, 1997, 112 (04) : A186 - A186
  • [24] Aspirin-triggered lipoxin in patients treated with aspirin and selective vs. non-selective COX-2 inhibitors
    Renda, G.
    Zurro, M.
    Santarelli, F.
    Sacchetta, D.
    Tacconelli, S.
    Zimarino, M.
    Patrignani, P.
    Romano, M.
    De Caterina, R.
    EUROPEAN HEART JOURNAL, 2007, 28 : 222 - 222
  • [25] Implication of reactive oxygen species (ROS) in gastroprotection and ulcer healing by nitric oxide (NO)-releasing aspirin.
    Brzozowski, T
    Kwiecien, S
    Drozdowicz, D
    Pawlik, M
    Konturek, SJ
    GASTROENTEROLOGY, 2000, 118 (04) : A246 - A246
  • [26] Selective COX-2 inhibitors, but not licofelone, a LOX/COX inhibitor, inhibit anti-adhesive activity of aspirin
    Fiorucci, S
    Mencarelli, A
    Distrutti, E
    Laufer, S
    Barbanti, M
    Palazzini, E
    Morelli, A
    Wallace, JL
    ANNALS OF THE RHEUMATIC DISEASES, 2003, 62 : 116 - 116
  • [27] Aspirin (ASA) and its nitric oxide (NO) derivative in the healing of colonic damage in experimental model of ulcerative colitis
    Sliwowski, Zbigniew
    Brzozowski, Tomasz
    Wcislo-Zwolinska, Malgorzta
    Konturek, Peter C.
    Pajdo, Robert
    Kwiecien, Slawomir
    Biesiada, Grazyna
    Konturek, Stanislaw J.
    Pawlik, Wieslaw W.
    GASTROENTEROLOGY, 2008, 134 (04) : A523 - A524
  • [28] Effects of aspirin and the natural COX-2 inhibitor quercetin on the development of esophageal adenocarcinoma in a rat model
    Hindmarsh, A
    Cheong, E
    Sams, V
    Igali, L
    Doleman, J
    Belshaw, N
    Lund, EK
    Rhodes, M
    Johnson, IT
    GASTROENTEROLOGY, 2004, 126 (04) : A651 - A651
  • [29] RE: Aspirin and COX-2 Inhibitor Use in Patients With Stage III Colon Cancer Response
    Ng, Kimmie
    Chan, Andrew T.
    Fuchs, Charles S.
    JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2015, 107 (08):
  • [30] The interaction between the preferential COX-2 inhibitor meloxicam and aspirin is statistically significant but not clinically relevant
    Fleuren, HWHA
    Gunnewiek, JMTK
    de Metz, M
    Vollaard, EJ
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2005, 59 (01) : 128 - 129
12345